What is T3 (Triiodothyronine)?
T3 (triiodothyronine) is the biologically active form of thyroid hormone that mediates the cellular actions of thyroid hormone by binding to nuclear receptor proteins to regulate gene expression and control metabolism throughout the body 1.
Physiological Role and Production
T3 represents the metabolically active thyroid hormone, while T4 (thyroxine) functions primarily as a prohormone. The thyroid gland directly secretes only about 20% of circulating T3, with the remaining 80% produced through peripheral tissue conversion of T4 to T3 via deiodinase enzymes 2, 3. This peripheral conversion occurs predominantly in the liver and other tissues, making T3 production a dynamic process influenced by multiple physiological factors.
The body prioritizes maintaining stable plasma T3 levels as a biological imperative, even when T4 and TSH levels fluctuate 2. This homeostatic mechanism underscores T3's critical importance for tissue function.
Clinical Significance
Protein Binding and Measurement
Approximately 99.7% of T3 circulates bound to serum proteins (primarily thyroxine-binding globulin), with only 0.3% existing as free T3 (FT3) 1, 3. While both total T3 and free T3 can be measured, total T3 measurement is frequently preferred in clinical practice because free T3 assays are less widely validated than free T4 assays 1.
Diagnostic Applications
T3 measurement is essential for diagnosing T3-toxicosis, a condition where T4 levels remain normal but T3 is elevated with suppressed TSH (<0.01 mU/L) 1, 4. This pattern may represent:
- Early stages of hyperthyroidism
- Disease caused by autonomously functioning thyroid nodules
- Specific presentations of Graves' disease
In overt hyperthyroidism, both free T4 and T3 are typically elevated with undetectable TSH. However, in milder cases, only T3 may be elevated while T4 remains normal 1.
Limited Role in Hypothyroidism Diagnosis
T3 measurement has minimal utility in diagnosing hypothyroidism because T3 levels often remain normal due to compensatory mechanisms: TSH hyperstimulation of remaining thyroid tissue and upregulation of type 2 deiodinase enzymes 5, 4. Additionally, T3 levels decrease in severe non-thyroidal illness independent of actual thyroid dysfunction 5.
Clinical Pitfalls and Considerations
Factors Affecting T3 Levels
Multiple conditions can alter T3 measurements without true thyroid disease:
- Protein binding abnormalities: Elevated TBG from pregnancy, estrogen, or hereditary causes increases total T3 without hyperthyroidism 1
- Medications: Amiodarone and high-dose propranolol inhibit T4-to-T3 conversion 1
- Severe illness: Reduces peripheral T4-to-T3 conversion 5
Treatment Implications
Recent evidence suggests that lower serum T3 levels in levothyroxine-treated patients constitute an independent risk factor for dyslipidemia, even when TSH is normalized 6. This challenges the adequacy of TSH-only monitoring and supports consideration of T3 homeostasis in treatment optimization.
For patients with persistent hypothyroid symptoms despite normalized TSH on levothyroxine monotherapy, guidelines support an individualized trial of adding liothyronine (synthetic T3) to levothyroxine 7, 8. However, this remains controversial, as randomized trials have shown inconsistent benefits, largely due to non-physiological T3 dosing regimens 9.
Key Laboratory Considerations
When interpreting T3 results:
- Normal TSH virtually excludes hyperthyroidism (except in rare TSH-producing pituitary adenomas or thyroid hormone resistance) 1
- Automated laboratory protocols should add T3 measurement when screening TSH is suppressed to avoid missing T3-toxicosis 1
- Cross-reactivity with T4 should be <0.2% and with reverse T3 <1.0% for reliable T3 assays 4
The measurement and interpretation of T3 requires understanding its unique physiology, production pathways, and the clinical contexts where it provides diagnostic value beyond TSH and T4 testing alone.